Category Archives: Medtronic Infuse

Featured Stories

64 More Plavix Patients File Suit Over Bleeding Side Effects

Another Plavix lawsuit has been filed on behalf of 64 Plavix patients who allege bleeding side effects. Plavix (clopidogrel) is a blood thinner prescribed for the prevention of blood clots and heart attacks, and has been linked to serious side effects, such as the heart attacks and strokes it is ...

Read More

Lawsuit Alleges Bi-Lateral DePuy ASR Hip Implant Resulted in Elevated Chromium and Cobalt Levels, Need for Revision Surgery

DePuy Orthopaedics and its parent, Johnson & Johnson, continue to be named in lawsuits by metal-on-metal hip replacement recipients who suffered severe injuries, including elevated chromium and cobalt levels, allegedly due to recalled ASR hip implant devices. Most recently, the national law firm of Parker Waichman LLP filed suit on ...

Read More

New York City Council Calls for Zadroga Act to be Renewed

New York City Council Calls for Zadroga Act to be Renewed

New York City Council members are calling for the Zadroga Act, which provides compensation and medical treatment to 9/11 victims, to be renewed. According to press release issued Jan. 7, a resolution was introduced by Council Member Margaret Chin, Council Speaker Melissa Mark-Viverito and Council Members Paul Vallone and I. ...

Read More

Long Island Car Crash Kills 1 Person, Injures 2 More

Long Island Car Crash Kills 1 Person, Injures 2 More

A car accident on LI left one person dead & two more critically injured. The crash occurred Monday in Deer Park on Straight Path, south of Sagamore Lane.

Read More

Stryker Metal Hip Implant Component Recall Bad News for Makers of Metal-on-Metal Hip Replacement Devices

Stryker’s recent recall of two metal hip implant components, the Rejuvenate Modular and ABG II modular-neck hip stems, may have dealt a serious blow to one of the key arguments medical device manufacturers have made to defend their metal-on-metal hip replacements. Facing thousands of lawsuits, the makers of ...

Read More

Crash on N.State Pkwy Kills Port Jefferson Station Man

Single-Car Crash on Northern State Parkway Kills Port Jefferson Station Man

81-year-old Port Jefferson Station man was killed in a crash at 4:57 a.m.. He lost control of the vehicle traveling west on Northern State Pkwy, on exit 42, Dix Hills.

Read More

Research Study Confirms Fracking Cause of Ohio Earthquakes

Research Study Confirms Fracking as Cause of Ohio Earthquakes

Fracking operation near Poland Township, Ohio, activated a previously unknown fault in the, causing 77 earthquakes with magnitudes ranging from 1.0 to 3.0 in March 2014.

Read More

Knee Replacement Patients Should Consider Nickel Allergies before Surgery

Individuals considering undergoing knee replacement surgery should ask their doctors to run a test to determine if they have a nickel allergy. Determining if a patient suffers from a nickel allergy will ensure the right knee implant is chosen for their surgery, and possibly save them from considerable pain and ...

Read More

Actos Side Effects Lawyers Says Whistleblower Revelations Could Boost Bladder Cancer, Heart Failure Lawsuits

An attorney with a prominent personal injury law firm says an Actos whistleblower lawsuit filed earlier this year could strengthen legal claims alleging the type 2 diabetes medication caused some users to develop bladder cancer and heart failure.

Read More

Zadroga Act Cancer Decision Expected This Week

The federal official tasked with determining what ailments should be covered by the federal Zadroga Act is expected to decide by Saturday if certain cancers will be eligible for compensation. The decision is being eagerly awaited by thousands of first responders who believe they developed cancer due to exposure ...

Read More

InFuse® Bone Graft No Better than Traditional Graft, Review Finds

infuse_bone_graft_effectiveness

An independent, dual review, found that Medtronic’s InFuse® product provided limited benefits. The bone graft product was also found to cause potential harm, including a small increased risk of cancer and works no better than traditional bone grafts, according to … Continue reading

Posted in Defective Medical Devices, Medtronic Infuse |

Yale’s Infuse® Bone Graft Study Expected in June

Yale_Infuse_Bone_Graft_study

A Yale University report concerning the bone graft product Infuse® is expected out next month. Device maker, Medtronic, commissioned Yale University researchers to conduct independent studies of its Infuse® bone graft products, allegedly in response to a June 2011 report … Continue reading

Posted in Defective Medical Devices, Medtonic Infuse, Medtronic Infuse |

Yale’s Medtronic Reporting Expected Next Month

Yale_Medtronic_Reporting

As the fallout from a conflict-of-interest scandal continues, drug maker Medtronic, announced in its fiscal fourth-quarter earnings report that the results from a long-awaited Yale review are expected to be published next month. Medtronic has been the focus of a … Continue reading

Posted in Defective Medical Devices, Medtonic Infuse, Medtronic Infuse |

Infuse® Maker, Medtronic, Cutting Staff

Infuse_Medtronic_Layoffs

Device maker, Medtronic Inc., just announced another scheduled staff cut. We recently wrote that Medtronic was laying off about 4 percent of its spinal business workforce worldwide, which amounted to about 230 of it spinal division’s 5,600 employees, This is … Continue reading

Posted in Defective Medical Devices, Medtonic Infuse, Medtronic Defibrillators, Medtronic Infuse |

Medtronic Cutting Spinal Business Workforce

Medtronic_Spinal_Cuts

Device maker, Medtronic Inc., is laying off about 4 percent of its spinal business workforce worldwide. The layoffs amount to about 230 of it spinal division’s 5,600 employees, said Twin Cities Business, according to Mass Device.com. As layoffs are being … Continue reading

Posted in Defective Medical Devices, Medtonic Infuse, Medtronic Infuse |

Expert: Spinal Fusion Surgery Linked with Increased Risks of Cancer

As spinal fusion surgery continues to be associated with controversy, probes, and patient injuries, a recent North American Spine Society (NASS) annual meeting discussed cancer links to products such as Medtronic’s InFuse®. Synthetic, or genetically engineered, recombinant human Bone Morphogenetic … Continue reading

Posted in Defective Medical Devices, Medtronic Infuse |

Medtronic INFUSE® Linked to Biased Studies, Emerging Injuries

Synthetic recombinant human Bone Morphogenetic Protein (rhBMP-2), manufactured by Medtronic under the brand INFUSE®, remains at the center of controversy following a government report and reports of new injuries associated with off-label use of the medical device. Late last year, … Continue reading

Posted in Defective Medical Devices, Medtonic Infuse, Medtronic Infuse |

Medtronic’s Infuse® Research Called Into Question

Medtronic has been at the center of a conflict-of-interest scandal following release of a government report that revealed that none of some 13 Medtronic-funded clinical trials reported Infuse® side effects. This, despite that data provided to federal regulators revealed that … Continue reading

Posted in Defective Medical Devices, Medtronic Infuse |

Medtronic Profits Plummet Amid Infuse® Troubles

The legal costs involved with its Infuse® bone growth product have led to a profit fall for Medtronic. As we’ve explained, Medtronic Infuse®—approved by the U.S. Food & Drug Administration (FDA) in 2002 to stimulate spine growth in patients suffering … Continue reading

Posted in Defective Medical Devices, Medtronic Infuse |

INFUSE controversy causing continual decline in Medtronic’s market share

As more negativity surrounds the Medtronic INFUSE bone growth product, the company’s market share and stock value continue to decline. According to a report from Trefis.com, a stock analysis service, the recent U.S. Senate findings that Medtronic manipulated purportedly scientific … Continue reading

Posted in Defective Medical Devices, Medtronic Infuse | Tagged , |

© 2005-2019 Parker Waichman LLP ®. All Rights Reserved.